Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 14, 2021NeurologyOpen Access

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYan LiSSSuzanne E. SchindlerJBJames G. Bollinger

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2021) studied this question.

synapsesocial.com/papers/69dafca00d8d6ef495a3ca4fhttps://doi.org/10.1212/wnl.0000000000013211
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011 · 7,297 citations
  2. 2Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 422014 · 371 citations
  3. 3Assessment of Racial Disparities in Biomarkers for Alzheimer Disease2019 · 394 citations
  4. 4Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease2017 · 82 citations